Abstract -Our recent screening program with higher plants has revealed many low m. w . compounds (e. g. alcaloids , quinones , terpenoids , phenolcarboxylic acids) and high m. w. compounds (e. g. polysaccharides, glycoproteins) with pronounced immunostimulating potential. The most promising low m.w. compounds are some cytostatic compounds, which are known for their direct antitumoral activities at high doses and exert immunostimulating effects when applied in minute doses. In the class of high m.w. compounds, primarily some complex acidic arabinogalactans or rhamnogalacturonans (e. g. Echinacea purp. , Achyrocline sat. , Urtica dioica) show significant immunostimulating activities in vitro and in vivo.
INTRODUCTION
The term immunostimulation comprises a prophylactic o r therapeutic concept which aims at the stimulation of our nonspecific immune system. This implies primarily the non antigen dependent stimulation of the function and efficiency of granulocytes, macrophages , complement and natural killer cells. In contrast to immunity achieved by immunization or antibody injection, this type of immunity, arising from unspecific immunostimulation, is termed paramunity (ref. 1) and the agents responsible are known as paramunity inducers.
I t is characteristic for these agents that they do not affect immunological memory cells. ,Their pharmacological efficacy fades quickly and must therefore be renewed by administering the drug either in intervals or continuously.
What do we expect from these kinds of drugs? Unspecific immunostimulation constitutes either an alternative to o r an adjuvant for conventional chemotherapy and prophylaxis of infections, for tumor-as well as autoimmune diseases, especially, when the host's immune system is impaired. Immunostimulation is also indicated to counteract immunosuppressions or an uneffectively working immune system, manifesting itself for example by a reduced resistance against infectious diseases, which may be the consequences of serious infections, physical and psychological stress, alcoholism, environmental damages such as pesticides, excessively applied chemotherapy, or long term treatment with immunosuppressive drugs. In undeveloped countries malnutrition can be another cause of a reduced resistance against infectious diseases.
DRUGS AVAILABLE TODAY
In the past, living and attenuated microorganisms autologous and heterologous proteins and injections of animal organ preparations were used with the aim of restoring an impaired defence mechanism. At present also thymus peptides and other Biological Response Modifiers (BRM) (e.g. interferon, interleukines), synthetic low molecular weight compounds (e.g. levamisol), chemically modified nucleotides , polysaccharides from fungi (e . g. lentinan) and, especially in Europe and China, some plant extracts are also used for the same purpose (ref. The absence of any breakthrough in this area has various reasons:
-many preparations e.g. the preparations from microorganisms and plants are not chemically defined or are insufficiently standardized.
-the few synthetic compounds are too toxic.
-the externally administered BRM can exhibit severe side effects when applied in a too high concentration o r at the wrong time, since they have also important regulatory functions. furthermore, at the moment we are still unable to match the dose of any immunostimulant to the prevailing immune status and general constitution of a patient and by this to predict and optimize the efficiency in a proper way. Therefore, we need more basic research as far as the mechanism of action of the immunostimulants is concerned.
-

SELECTION OF DRUGS AND COMPOUNDS FOR SCREENING
In ,the search for plant constituents with immunostimulating potency one can select those plant drugs which so far have been used in traditional medicine. In the old literature you will not find the term immunostimulation. One can assume, however, that many plants 
RECENT RESULTS a) Low molecular weight compounds (Fig. 1)
The first chemically defined N-containing plant constituent which was found to exert immunostimulating activity, was aristolochic acid (ref. 5 ) . In a double blind study 0,9 mgldie administered orally over 21 days showed a significant enhancement of phagocytosis with a maximum on the 6th/8th day.
From the six oxindol alcaloids, isolated from the Peruvian plant Uncaria tomentosa ("Una de gatol'), isopteropodin-HC1 (2) was shown to be a phagocytosis in the concentration range of pteropodin and the other alcaloids were much less active or inactive respectively, structure-activity relationships in the class of compounds must exist. The observation that most of the investigated alcaloids (e. g. emetine, berberine, .gelsemine) showed immunosuppressive o r cytotoxic effect when used in high doses and exhibited immunostimulatory properties only in very low doses has prompted us to investigate more closely this dose-dependent reversal effect. The naphthoquinone plumbagin (3) from Plumbago zevlanicum exerts in vitro immuno-suppressive o r cytotoxic activity against primary cell cultures of granulocytes in a concentration range of 100 yg -100 nglml, whereas it s$imulates the same granulocytes in the extremely low concentration range of 100 pg -fg /ml (ref. 
Since it has been reported that cells whose activities are suppressed are more sensitive than "noninfluenced cells", we exposed lymphocytes to a brief cold treatment (cooling to 4OC f o r 1 hr) and incubated them afterwards with vincristine, using the same concentration ranges. W e found that cold treatment resulted in a statistically significant increase in the stimulation rate ( 14, 15, 1 6 ) , various synthetic and microbial cytostatic agents (e. g. cytosin arabinoside, methotrexate or adriamycin) are able to achieve in vitro a differentiation of myeolotic leukemia cells and thereby a reversion of malignancy at doses of 3-7 ng/ml. Induction of differentiation was explained by the production of colony stimulating inducer proteins/MG T-2) as modulators or inhibitors of oncogene expression, respectively. When this triggering effect of cell differentiating processes by low doses of immunostimulatory agents can also be exhibited in vivo, a new promising concept of tumor therapy would be available ( ref. 1 7 ) .
In the light of all these new findings, it is plausible to assume that many cancer drugs of plant origin such as e. g. mistletoe (Viscum album), the South American lapacho (Tabebuia avellanedael, the extract of Dionaea muscipula and others exert their antitumor activities by a total or partial immune induced mechanism of action.
If we survey the vast number of plant drug constituents which may act as immunostimulators, we find also compounds which are neither irritants nor cytotoxic in high doses or carcinogenic. A detailed monitoring of extracts of Echinacea spp. with several in vitro and in vivo immunological assays revealed isobutvlamides (61, phenolcarboxylic acid esters (i.e. The natural products described so far can be classified as granulocyte-, macrophage-and/or lymphocyte stimulators.
Since the human complement system also plays a very pronounced role in the immune defence system and in inflammation processes, we also have estab-lished an in vitro test system for screening isolated compounds for their complement activating effect on the classical and alternative cascade of the complement system (ref. 20) . Besides rosmarinic acid, some cinnamic acid derivatives and a few flavonol-acyl-glycosides as well as some triterpenoic acids were found to inhibit significally the classical way of complement cascade. (Table 2 ) . In the last 20 years, a great number of water soluble polysaccharides with reported immunostimulating potential have been isolated from higher plants In table 3 the most intensively studied plants with respect to their polysaccharide composition are listed, The immunostimulating potential of these polysaccharides is described as "enhancing the phagocytosis of granulocytes and macrophages" , "inducing the Interferone-, Interleukine-, Tumor necrosis factor -production", t'complement activating" or t'antitumoraltT.
The term "antitumoralt' , first defined for several polysaccharides from fungi and algae includes several kinds of interactions, in which macrophages as well as T-lymphocytes, NKcells and their mediators can be involved. The expression "complement activating" can be understood or interpreted as an antigen processing mechanism or as an antiinflammatory activity because most of the complement tests measure the complement consumption only.
Since it is obvious that the various polysaccharides do not have the same sides of attack in the immune system, it is at present hardly possible to draw a clear structure activity relationship and indicate which structural features are essential for an optimally immunostimulating activitiy. As far as the phagocytosis and macrophage stimulation is concerned, it is remarkable that neutral xyloglucans and glycuronic acid containing arabinogalactans or 4-0- It is assumed that the fine structures of these polysaccharide, i. e. the tertiary structures, affect the mode of action.
As prototypes of both classes, the following polysaccharides are described in details:
Echinacea species are the starting material of many phytopreparations in Germany and other countries of Europe. The roots of Echinacea purpurea or E. angustifolia have been used by the Indians of North America for wound healing and the treatment of infections. Today, extracts of both plants are claimed to have immunostimulating activity and are used prophylactically and therapeutically as adjuvants for the management of infectious diseases and in particular for the treatment of chronic bronchitis, sinusitis and influenza. Besides some low molecular weight compounds (see first part) two chemically defined polysaccharides with immunostimulating activity have been isolated from the upper part of Echinacea purpurea (ref. interferon-I32 and oxygen radicals, the latter as measured by chemoluminescence. The arabinogalactan did not activate B-cells and did not induce T cells to produce interleukin-2, interferon-p2 o r interferon-, but generated a slight increase of T-cell proliferation (ref. 25) . The great advantages of this polysaccharide are that it seems to act rather selectively on macrophages and that it is nontoxic over a wide dose range (acute toxicity > 4 g/kg ip or. i.v.). Specific immune responses to red blood cells of sheep (antibody production) and to listeria (DTH) were not affected by this polysaccharide. The positive infection stress tests performed with mice let us assume that this polysaccharide is a promising candidate for clinical trial.
The nearly exclusive activity of the Echinacea polysaccharide on granulocytes and macrophages is in some way unique, since e.g. an acidic arabinogalactan from mistletoe (Viscum album) of similar chemical composition does not enhance TNF from macrophages but strongly activates complement (ref. 26) .
In contrast to this compound, two further polysaccharides isolated from Achvrocline satureioides (Asteraceae) , showed immunological activities in a great number of test models (ref. 27 ). Both rhamnose, xylose and arabinose containing glykanogalakturonans (m. w . = 7.600, 15.000 D) (1) enhanced strongly the granulocyte and macrophage phagocytosis , showed a moderate effect on the TNF-a induction and exerted a strong anticomplementary activity in the classical as well as in the alternative pathway. It is likely that these anticomplementary properties are responsible for the antiphlogistic activities of both polysaccharides as measured in the rat paw oedema model (ref.27) . In comparison to indometacin (10 mg/kg) both polysaccharides exhibited the same activity (25-30% oedema reduction in 8 hrs) at concentrations of 3 mg/kg at i.v. administration.
The same correlation between the anticomplementary in vitro effect and the antiphlogistic activity in experimental animals has also been found for a polysaccharide mixture from Urtica dioica (ref. 28). If we compare our results on the anticomplementary activities of polysaccharides from higher plants with those of Ymada's group, we find a good congruence in that most of them are pectic heteroglycans with a relatively high proportion of galacturonan backbones. This finding is in accordance with our other finding that the most active anticomplementory polysaccharides from algae were found to be sulfated polysaccharides such as -carrageenan, fucoidans, and heparin (ref. 29) . However, there are also neutral polysaccharides, e. g. Lentinan from the fungus Lentinus edodes and amylose, occurring widely in fruits and roots, which were found to be good anticomplementary active polysaccharides (ref. 20) .
In this context we should also mention the so called "antitumoral" polysaccharides from fungi, e. g. Lentinan, (Lentinus edodes) , Schizophyllan (Schizophyl-lum commune) o r Krestin (Coriolus versicolor) . These antitumor polysaccharides, in most cases, were shown to be glucans with different types of glycosidic linkages. Some structural features were obvious prerequisites: i.e. p-l-->3-linkages in the main chain of the glucan core and further p-1,6 branch points. Krestin is a p-1,4-glucan with ~-1,6-glucopyranosidic side chains for every fourth glucose unit, containing a covalent bound peptide residue. The clinical usefulness of these polysaccharides mainly in combination with chemotherapy has been demonstrated with patients suffering from lung-, gastric-, colon-and cervical cancer (ref. 30) . In general i.m. injections once or twice per week with single doses, ranging from 2mg to 30 mg of these polysaccharides were shown to be effective in prolonging considerably the survival period of the patients. From the in vitro-and in vivo experiments performed so far, it can be concluded that these glucans exert their immune induced antitumor activities primarily by stimulating lymphocytes to liberate lymphokines (IL 2 , MAF) , thus activating NK-cells and macrophages .
As far as Krestin, a protein with covalently bound polysaccharide, is concerned, it is not clear whether o r to which extent the protein part attributes to the immunological activity of this compound. On the other hand there are a series of lycoproteins and proteins such as lectins (e.g. concanavalin A ) , which exert modulatory influences within the immune system. The targets for these kinds of plant derived polymers are at first hand T-lymphocytes, NK-cells and the complement. E.g. it has been shown that nontoxic doses of the pgalactoside -specific lectin ML I from mistletoe (Viscum album) is able to activate tumoricidal effector mechanisms in experimental animals as well as in patients (ref. 31) .
